Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DDB29082.svg?ark=w1%2F20260515%2FDDB29082)](https://nobleid.org/work/w1/20260515/DDB29082)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors